2023年8月23日 · Invokana is an oral diabetes medicine that helps control blood sugar levels. Canagliflozin works by helping the kidneys get rid of glucose from your bloodstream. Invokana …

2024年6月16日 · Invokana (canagliflozin) is commonly used to help lower blood sugar levels in people with type 2 diabetes. Invokana is also used in people with type 2 diabetes and either …

2025年1月15日 · Invokana (canagliflozin) is a sodium-glucose co-transporter 2 (SGLT2) inhibitor used to control blood sugar in people with type 2 diabetes mellitus, in addition to diet and …

Initial: 100 mg PO daily taken before first meal of the day. May increase dose to 300 mg daily if 100 mg/day tolerated in patients who have eGFR ≥60 mL/min/1.73 m² and require additional...

INVOKANA ® (canagliflozin) is a prescription medicine used: along with diet and exercise to lower blood sugar (glucose) in adults with type 2 diabetes to reduce the risk of major cardiovascular …

Medication Guide INVOKANA® (in-vo-KAHN-uh) (canagliflozin) tablets, for oral use the most important information I should know about INVOKANA? • Diabetic ketoacidosis (increased …

Assess volume status and correct volume depletion before initiating (2.1). The recommended starting dosage in adults and pediatric patients aged 10 years and older with type 2 diabetes …

2025年3月20日 · The maximum recommended dosage of INVOKANA is 300 mg once daily. In patients with eGFR less than 60 mL/min/1.73 m 2, increase to a maximum recommended …

INVOKANA ® is not recommended to decrease blood sugar (glucose) in people with type 2 diabetes with severe kidney problems. It is not known if INVOKANA ® is safe and effective in …

INVOKANA®: the first SGLT2i approved for initiation in adult patients with T2D and an eGFR as low as 30 who have DKD,* established CVD, or are in need of glycemic control 1-4